4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Hospital Corporation of China Limited (3869) operates in the Medical Care Facilities industry and is headquartered in Beijing, China with about 1,809 employees. Its market capitalization is roughly CNY 464 million. In the fiscal year ended 2025-12-31, 3869 reported CNY 1.5B in revenue and CNY 136M in net income.
Hospital Corporation of China Limited, an investment holding company, owns, operates, and manages hospitals in the People's Republic of China. It operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 1.5B | CNY 1.4B | CNY 1.4B | CNY 1.1B | — |
| Gross Profit | CNY 268M | CNY 276M | CNY 239M | CNY 151M | — |
| Operating Income (EBIT) | CNY 159M | CNY 180M | CNY 124M | CNY 61M | — |
| Net Income | CNY 136M | (CNY 26M) | CNY 131M | (CNY 481M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | (CNY 31M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 2.6B | CNY 2.6B | CNY 2.5B | CNY 2.4B | — |
| Total Liabilities | CNY 1.9B | CNY 2.0B | CNY 1.9B | CNY 2.0B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3869 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms